Dual thio-digalactoside-binding modes of human galectins as the structural basis for the design of potent and selective inhibitors
Hsieh, T.J., Lin, H.Y., Tu, Z., Lin, T.C., Wu, S.C., Tseng, Y.Y., Liu, F.T., Danny Hsu, S.T., Lin, C.H.(2016) Sci Rep 6: 29457-29457
- PubMed: 27416897 
- DOI: 10.1038/srep29457
- Primary Citation of Related Structures:  
- PubMed Abstract: 
Human galectins are promising targets for cancer immunotherapeutic and fibrotic disease-related drugs. We report herein the binding interactions of three thio-digalactosides (TDGs) including TDG itself, TD139 (3,3'-deoxy-3,3'-bis-(4-[m-fluorophenyl]- ...